Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT

• Váldodahkkit: Masatoshi Abe (Dahkki), Yukari Okubo (Dahkki), Hidetoshi Takahashi (Dahkki), Koki Endo (Dahkki), Siddharth Chaudhari (Dahkki), Cynthia Deignan (Dahkki), Hamid Amouzadeh (Dahkki), Ryosuke Hino (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Adis, Springer Healthcare, 2024-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Introduction Psoriasis involvement in special areas (e.g., scalp or nails) is associated with a great disease burden yet it is often inadequately treated with topical treatments. The efficacy and tolerability of apremilast plus existing topical therapy in Japanese patients with mild to mode...